Skip to Content search facebook instagram pinterest twitter youtube

Publications

TTANGO and TTANGO2 Publications

The TTANGO Trial Final Report To Health Services May 2018

Read the final report

 

Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation.

Causer LM, Guy RJ, Tabrizi SN, Whiley D, Speers D, Ward J, Tangey A, Badman SG, Hengel B, Natoli L, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM. Molecular testing for chlamydia and gonorrhoea used at point-of-care in remote primary health care settings: a diagnostic evaluation. Sexually Transmitted Infections (accepted 2018) available online at doi:10.1136/sextrans-2017-053443

 

A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.

Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi S, Speers D, Shephard MD, Vallely A, Whiley D on behalf of the TTANGO investigators. A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing. Pathology 2018;50: 317-321 https://doi.org/10.1016/j.pathol.2017.09.012

 

A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis.

Badman SG, Causer LM, Guy R, Tabrizi S, Francis F, Donovan B, Whiley D on behalf of the TTANGO Investigators (including Shephard M). A preliminary evaluation of a new GeneXpert (Gx) molecular point-of-care test for the detection of Trichomonas vaginalis. Sexually Transmitted Infections 2016; 92: 350-352. doi:10.1136/sextrans-2015-052384

 

A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting.

Natoli L, Guy RJ, Shephard M, Causer L, Badman SG, Hengel B, et al. “I Do Feel Like a Scientist at Times”: A Qualitative Study of the Acceptability of Molecular Point-Of-Care Testing for Chlamydia and Gonorrhoea to Primary Care Professionals in a Remote High STI Burden Setting. PLoS ONE 2015; 10(12): e0145993. http://dx.doi.org/10.1371/journal.pone.0145993

 

Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study.

Natoli L, Guy RJ, Shephard M, Whiley D, Tabrizi SN, Ward J, Regan DG, Badman SG, Anderson DA, Kaldor J, Maher L on behalf of the TTANGO investigator group. Public health implications of molecular point-of-care testing for chlamydia and gonorrhoea in remote primary care services in Australia: a qualitative study. BMJOpen 2015; 5:e006922. doi:10.1136/bmjopen-2014-006922

 

Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used?

Natoli L, Guy RJ, Shephard M, Donovan B, Fairley C, Ward J, Regan D, Hengel B, Maher L on behalf of the TTANGO Investigators. Chlamydia and gonorrhoea point-of-care testing in Australia: where should it be used? Sexual Health 2015; 12: 51-58. http://dx.doi.org/10.1071/SH14213

 

Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Natoli L, Maher L, Shephard M, Hengel B, Tangey A, Badman S, Ward J, Guy R on behalf of the TTANGO investigators. Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice. PLoS ONE 2014; 9(6): e100518. http://dx.doi.org/10.1371/journal.pone.0100518

 

A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol.

Guy R, Natoli l, Ward J, Causer L, Hengel B, Whiley D, Tabrizi S, Donovan B, Fairley C, Badman S, Tangey A, Wand H, Shephard M, Regan D, Wilson D, Anderson D, Kaldor J. A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote communities: Test, Treat And GO- the ‘TTANGO’ trial protocol. BMC Infectious Diseases 2013; 13: 485. doi:10.1186/1471-2334-13-485

 

Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis.

Tabrizi S, Unemo M, Golparian D, Twin J, Limnios A, Lahra M, Guy R, Ward J, Kaldor J, Donovan B, Wilson D, Wand H, Regan, D, Causer L, Hengel B, Natoli L, Anderson D, Whiley D, Shephard M, Fairley, C. Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology 2013; 51: 1945-1947. doi:10.1128/JCM.00806-13